课题基金 / 基金详情

DIABETES PREVENTION PROGRAM (DPP)

DIABETES PREVENTION PROGRAM (DPP)
糖尿病预防计划 (DPP)
批准号：
6114061
负责人：
Mark Ellis Molitch
金额：
$2.05万
依托单位：
NORTHWESTERN UNIVERSITY AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6114061
关键词：
clinical research clinical trials disease /disorder prevention /control glucose tolerance glucose tolerance test human subject lifestyle metabolism disorder chemotherapy metabolism disorder diagnosis metformin noninsulin dependent diabetes mellitus

项目摘要

项目成果

Mark Ellis Molitch的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Impaired glucose tolerance represents a category of results from glucose tolerance tests that is not completely normal nor meets criteria for NIDDM.. About half of all subjects found to have IGT progress to NIDDM over time with a rate of about 5% per year. The purpose of this randomized, prospective multicenter clinical trial is to determine whether the progression from IGT to NIDDM in high risk populations can be prevented or delayed with specific interventions, including intensive lifestyle change and metformin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS (EDIC)
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS (EDIC)
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS (EDIC)
海外基金